Cargando…
Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer’s Disease and Down Syndrome
The neurotrophin Nerve Growth Factor (NGF) holds a great potential as a therapeutic candidate for the treatment of neurological diseases. However, its safe and effective delivery to the brain is limited by the fact that NGF needs to be selectively targeted to the brain, to avoid severe side effects...
Autores principales: | Capsoni, Simona, Cattaneo, Antonino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961408/ https://www.ncbi.nlm.nih.gov/pubmed/35360160 http://dx.doi.org/10.3389/fnins.2022.773347 |
Ejemplares similares
-
Intranasal “painless” Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice
por: Capsoni, Simona, et al.
Publicado: (2012) -
Correction: Intranasal “painless” Human Nerve Growth Factors Slows Amyloid Neurodegeneration and Prevents Memory Deficits in App X PS1 Mice
por: Capsoni, Simona, et al.
Publicado: (2012) -
The effects of painless nerve growth factor on human microglia polarization
por: Lisi, Lucia, et al.
Publicado: (2022) -
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor
por: Capsoni, Simona, et al.
Publicado: (2017) -
Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis
por: Braschi, Chiara, et al.
Publicado: (2020)